Eric P. Loukas, Industry Veteran, Named as CEO
Frank Jacobucci Co-Founder, Named as President and COO
ALTAMONTE SPRINGS, Fla., Aug. 14 /PRNewswire/ -- Milestone Biosciences, LLC, a privately held specialty biotechnology company focused on in-licensing and commercialization of niche oncology products, today announced the appointment of Eric P. Loukas as Chief Executive Officer, effective August 12, 2008. Current President, CEO and Co-founder, Frank Jacobucci, will become President and Chief Operating Officer and will continue to be heavily involved in the company's development, growth and expansion.
"We are pleased to welcome Mr. Loukas to our team. His leadership skills combined with his strategic and industry insight will provide Milestone with the depth of expertise required as we move forward at an accelerated pace, said Frank Jacobucci, Milestone's President and COO.
"I am excited to join Milestone Biosciences at this important stage of its growth," commented Mr. Loukas. "The company's unique business model will provide the opportunity for cancer patients to have access to a broader range of therapies and I look forward to working with the rest of the team and our partners to realize the full potential of this innovative company."
Mr. Loukas brings to the team over 21 years of industry experience.
Prior to joining Milestone, Mr. Loukas was Executive Vice President, Chief
Operating Officer, General Counsel and Corporate Secretary of MGI PHARMA,
INC., where he was responsible for MGI's commercial, medical affairs,
manufacturing, regulatory, quality, government affairs, reimbursement and
legal operations. Mr. Loukas joined MGI in July 2004 as Senior Vice
President, General Counsel and Corporate Secretary. Prior to joining MGI,
he served as Division Counsel at 3M Pharmaceuticals, a division of 3M
Company, where he provided legal and strategic counsel to the global
management team of a $1 billion pharmaceutic
|SOURCE Milestone Biosciences, LLC|
Copyright©2008 PR Newswire.
All rights reserved